Stockscreener 앱 받기
1.22
2.52%
0.03
시장 영업 전:
1.21
-0.01
-0.82%
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Stock Titan
Is Cardiol Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com
What analysts say about Cardiol Therapeutics Inc. stockTremendous financial leverage - Autocar Professional
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
What drives Cardiol Therapeutics Inc. stock pricePowerful market insights - Autocar Professional
Cardiol Therapeutics Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% – Here’s What Happened - Defense World
Cardiol Therapeutics shares rise 3.88% premarket after CMS achieves secondary listing on Singapore Exchange. - AInvest
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityFree Short-Term Stock Picks - Newser
What makes Cardiol Therapeutics Inc. stock price move sharplyBreakout Momentum Alerts - Newser
(CRDL) On The My Stocks Page (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 10.8% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Trading Up 1% – Here’s Why - Defense World
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World
(CRDL) Financial Trading Report (CRDL:CA) - news.stocktradersdaily.com
Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World
All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus
H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus
(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data - Investing News Network
Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise - SECFilings.com
Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile
Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan
Cardiol Therapeutics Reports Q1 2025 Financial Results - TipRanks
Cardiol Therapeutics to Webcast Virtual Annual General Meeting o - GuruFocus
(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc. - Baystreet.ca
Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com
1.97%
0.68%
자본화:
|
볼륨(24시간):